Based on the results of the tumor challenge and growth, it was concluded that PAP-specific immune activation occurred in the mice treated with the PAP-fused cytokines, and the antitumor effects were significantly enhanced by the additional cytokine (IL2, IL4 and IL7) fusion proteins. Here, IL4 is linked to neoplasm.